Login / Signup

Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.

Anders GranholmMarie Warrer MunchSheila Nainan MyatraBharath Kumar Tirupakuzhi VijayaraghavanMaria CronhjortRebecka Rubenson WahlinStephan M JakobLuca CioccariMaj-Brit Nørerregaard KjaerGitte Kingo VesterlundTine Sylvest MeyhoffMarie HellebergMorten Hylander MöllerThomas BenfieldBalasubramanian VenkateshNaomi HammondSharon MicallefAbhinav BassiOommen JohnVivekanand JhaKlaus Tjelle KristiansenCharlotte Suppli UlrikVibeke Lind JørgensenMargit SmittMorten H BestleAnne Sofie AndreasenLone Musaeus PoulsenBodil Steen RasmussenAnne Craveiro BrøchnerThomas StrømAnders MøllerMohd Saif KhanAjay PadmanabanJigeeshu Vasishtha DivatiaSanjith SaseedharanKapil BorawakeFarhad KapadiaSubhal DixitRajesh ChawlaUrvi ShuklaPravin AminMichelle S ChewChristian GluudTheis LangeAnders Perner
Published in: Acta anaesthesiologica Scandinavica (2021)
ClinicalTrials.gov: NCT04509973; EudraCT: 2020-003363-25.
Keyphrases
  • coronavirus disease
  • sars cov
  • randomized controlled trial
  • study protocol
  • low dose
  • high dose
  • endothelial cells
  • early onset
  • phase ii
  • respiratory syndrome coronavirus
  • open label